Search Within

Martin Stuart Tallman

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (9)
Groups
  1. Adult Leukemia (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. GSK Faculty (18)
  5. Hematologic Malignancies, Division of (18)
  6. Molecular Pharmacology and Chemistry Program Faculty (18)

More Groups

People
  1. Ross Levine (11)
  2. Jae Park (9)
  3. Eunhee Kim (7)
  4. Neal Rosen (7)
  5. Omar Abdel-Wahab (7)
  6. Stephen Chung (7)

More People

Years
  1. 2018 (2)
  2. 2017 (2)
  3. 2016 (2)
  4. 2015 (5)
  5. 2014 (5)
  6. 2013 (1)

More Years

Publications
  1. Blood (7)
  2. Blood Advances (1)
  3. Cancer Discovery (1)
  4. Cancer Research (1)
  5. Haematologica (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. American Association for Cancer Research (2)
  3. Nature Publishing Group (2)
  4. American Association for the Advancement of Science (1)
  5. American Society for Clinical Investigation (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program
    Journal Article

    Park, S. M.; Gönen, M.; Vu, L.; Minuesa, G.; Tivnan, P.; Barlowe, T. S.; Taggart, J.; Lu, Y.; Deering, R. P.; Hacohen, N.; more...
    Journal of Clinical Investigation (2015)

    Fulltext@MSK | Save
  • Context specific effects of the BRAFV600E mutation on hematopoiesis identifies novel models of BRAF mutant hematopoietic disorders
    Meeting Abstract

    Kim, E.; Chung, S. S.; Park, J. H.; Chung, Y. R.; Lito, P.; Feldstein, J.; Hu, W. H.; Beguilin, W.; Monette, S.; Duy, C.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Msi2 maintains the MLL leukemia stem cell regulatory program
    Meeting Abstract

    Park, S. M.; Gonen, M.; Vu, L. P.; Minuesa, G.; Tivnan, P.; Barlowe, T.; Taggart, J.; Lu, Y. H.; Deering, R. P.; Hacohen, N.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Brafv600e mutations in hematopoietic stem cells of hairy cell leukemia patients suggests a stem cell origin
    Meeting Abstract

    Chung, S. S.; Kim, E.; Park, J. H.; Chung, Y. R.; Feldstein, J.; Hu, W.; Rampal, R.; Patel, M.; Kim, M. K.; Huberman, K.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia
    Journal Article

    Chung, S. S.; Kim, E.; Park, J. H.; Chung, Y. R.; Lito, P.; Teruya-Feldstein, J.; Hu, W.; Béguelin, W.; Monette, S.; Duy, C.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • BRAFV600E mutations occur in the hematopoietic stem cell compartment in hairy cell leukemia
    Meeting Abstract

    Chung, S. S.; Park, J. H.; Kim, E.; Chung, Y. R.; Hu, W.; Lito, P.; Feldstein, J. T.; Rampal, R. K.; Telis, L.; Patel, M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save